| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0008 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |